𝔖 Bobbio Scriptorium

✦ LIBER ✦

Enoxaprin may be more effective than unfractionated heparin for people with high-risk non ST-segment elevation acute coronary syndromes

✍ Scribed by Blair J O’Neill; Debbie Singh

Book ID: 119231197
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 76 KB
Volume: 10
Category: Article
ISSN: 1361-2611
DOI: 10.1016/j.ebcm.2006.04.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enoxaparin appears as effective as unfra

Enoxaparin appears as effective as unfractionated heparin for people with high risk non-ST elevation acute coronary syndromes receiving rapid invasive therapy

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

At six months, enoxaparin is more effect

At six months, enoxaparin is more effective than tinzaparin for people with non ST-segment elevation acute coronary syndromes

✍ Marc Cohen; Debbie Singh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Activated partial thromboplastin time me

Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin

✍ Michael P. Thomas, Kenneth W. Mahaffey, Karen Chiswell, Marc Cohen, Michael C. K 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 268 KB

Enoxaparin vs. unfractionated heparin in

Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-Segment elevation acute coronary syndromes managed with an intended early invasive strategy—primary results of the SYNERGY randomized trial

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Randomized evaluation of the safety and

Randomized evaluation of the safety and efficacy of enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

✍ S.G. Goodman; D. Fitchett; P.W. Armstrong; M. Tan; A. Langer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Randomized evaluation of the efficacy of

Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial

✍ David H. Fitchett; Anatoly Langer; Paul W. Armstrong; Mary Tan; Aurora Mendelsoh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB